Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Spectrum Pharma: Q3 Earnings Snapshot

11/10/2021 | 04:09pm EST

HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Wednesday reported a loss of $33.1 million in its third quarter.

On a per-share basis, the Henderson, Nevada-based company said it had a loss of 21 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SPPI at https://www.zacks.com/ap/SPPI

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about SPECTRUM PHARMACEUTICALS, INC.
01/20Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Co..
BU
01/06SPECTRUM PHARMACEUTICALS : Announces New Strategic Investment by Hanmi Pharmaceutical - Fo..
PU
01/06SPECTRUM PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Unregistered Sa..
AQ
01/05Spectrum Pharmaceuticals to Cut 30% of Staff, Prioritize Late-Stage Programs in Restruc..
MT
01/05Spectrum Pharmaceuticals Announces Strategic Restructuring
BU
01/05Spectrum Pharmaceuticals Announces Strategic Restructuring
CI
01/04Spectrum Pharmaceuticals to Get $20 Million Equity Investment from Hanmi Pharmaceutical
MT
01/04Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
BU
01/04Spectrum Pharmaceuticals, Inc. announced that it expects to receive $20 million in fund..
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from S&P Biotechnology Select Industr..
CI
More news
Analyst Recommendations on SPECTRUM PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -152 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,03x
Yield 2021 -
Capitalization 174 M 174 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 4,86x
Nbr of Employees 176
Free-Float -
Chart SPECTRUM PHARMACEUTICALS, INC.
Duration : Period :
Spectrum Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPECTRUM PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 1,01 $
Average target price 5,75 $
Spread / Average Target 469%
EPS Revisions
Managers and Directors
Thomas J. Riga President, Chief Executive Officer & Director
Kurt A. Gustafson Chief Financial Officer & Executive Vice President
William L. Ashton Chairman
Francois Lebel Chief Medical Officer
Lyndah K. Dreiling Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
SPECTRUM PHARMACEUTICALS, INC.-20.47%174
MODERNA, INC.-31.46%70 577
LONZA GROUP AG-14.10%53 088
IQVIA HOLDINGS INC.-14.84%45 903
SEAGEN INC.-14.26%24 238
ICON PUBLIC LIMITED COMPANY-17.00%20 923